Treatment
- abiraterone
- anastrozole
- bicalutamide
- capecitabine
- CAPOX
- carboplatin
- cetuximab
- cisplatin
- crizotinib
- dacarbazine
- docetaxel
- doxorubicin
- epirubicin
- erlotinib
- everolimus
- exemestane
- fluorouracil
- flutamide
- FOLFOX
- FOLFIRI
- fulvestrant
- gefitinib
- gemcitabine
- goserelin
- imatinib
- irinotecan
- lapatinib
- letrozole
- leuprolide
- liposomal doxorubicin
- megestrol acetate
- nab-paclitaxel
- oxaliplatin
- paclitaxel
- panitumumab
- pemetrexed
- pertuzumab
- sorafenib
- sunitinib
- tamoxifen
- temozolomide
- temsirolimus
- topotecan
- toremifene
- trastuzumab
- vemurafenib
carboplatin
Carboplatin is an alkylating agent that works by attaching an alkyl group to the guanine
base of DNA. Because cancer cells often proliferate more quickly and are less able to
correct DNA errors than normal cells, they are more sensitive to DNA damage caused
by alkylation.
Carboplatin is indicated* for the initial treatment of ovarian cancer that has spread
beyond the ovaries in combination with other approved chemotherapy drugs.
Carboplatin is also indicated for palliative treatment in patients with ovarian cancer that
has recurred after therapy with other drugs.
*Please refer to full prescribing information/package insert for precise indications.
